NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that it has entered ...

CHARLESTON, W.Va. — Off-label uses of opioid products dominated testimony Friday in the ongoing trial pitting the state of West Virginia against three opioid manufacturers. The lawsuit alleges Johnson ...

Clinical trials are vital for the design and development of safe drugs, treatments, and medical interventions and bringing them to market. Often, the idea for a clinical trial starts in the laboratory ...

This is the inaugural transaction in the European Loan Market, and first fundraising outside LATAM, for the Brazilian-founded multinational. The Company is expected to achieve ~€550 Million in revenue ...

Chaim Lebovits, President and CEO, stated that "our unwavering primary focus remains the execution of the clinical development plan for NurOwn and the initiation of our pivotal Phase 3b trial designed ...

Developers of a cutting-edge lab-grown blood vessel designed to save life and limb in war zones and other emergency scenarios ...

Ongoing open-label extension trials of simufilam in Alzheimer’s disease to be extended by up to an additional 36 months. The extension provides participants the opportunity to continue on treatment, ...